Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
interferon alpha-2b (Intron-A) (1 trial)
phyllanthus (1 trial)
Fatty Liver (Phase 2)
Leukemia (Phase 3)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 3)
Liver Diseases (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Trials (2 total)
Trial APIs (2 total)